The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)
Open accessAbstract
OBJECTIVE: To determine the most critical symptoms in a national myotonic dystrophy type 1 (DM1) population and to identify the modifying factors that have the greatest effect on the severity of these symptoms. METHODS: We performed a cross-sectional study of 278 adult patients with DM1 from the national registry of patients with DM1 between April and August 2010. We assessed the prevalence and relative significance of 221 critical DM1 symptoms and 14 disease themes. These symptoms and themes were chosen for evaluation based on prior interviews with patients with DM1. Responses were categorized by age, CTG repeat length, gender, and duration of symptoms. RESULTS: Participants with DM1 provided symptom rating survey responses to address the relative frequency and importance of each DM1 symptom. The symptomatic themes with the highest prevalence in DM1 were problems with hands or arms (93.5%), fatigue (90.8%), myotonia (90.3%), and impaired sleep or daytime sleepiness (87.9%). Participants identified fatigue and limitations in mobility as the symptomatic themes that have the greatest effect on their lives. We found an association between age and the average prevalence of all themes (p < 0.01) and between CTG repeat length and the average effect of all symptomatic themes on participant lives (p < 0.01). CONCLUSIONS: There are a wide range of symptoms that significantly affect the lives of patients with DM1. These symptoms, some previously underrecognized, have varying levels of importance in the DM1 population and are nonlinearly dependent on patient age and CTG repeat length.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of Ranks in One-Criterion Variance Analysis
Kruskal, W. H., & Wallis, W. A. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10483441 · Cited by 13,912
Patient-Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective
Patrick, D. L., Burke, L. B., Powers, J. H., Scott, J. A., Rock, E. P., Dawisha, S., O'Neill, R., & Kennedy, D. L. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00275.x · Cited by 726
What Is Sufficient Evidence for the Reliability and Validity of Patient-Reported Outcome Measures?
Frost, M. H., Reeve, B. B., Liepa, A. M., Stauffer, J. W., & Hays, R. D. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00272.x · Cited by 572
Patient-Reported Outcomes: Instrument Development and Selection Issues
Turner, R. R., Quittner, A. L., Parasuraman, B. M., Kallich, J. D., & Cleeland, C. S. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00271.x · Cited by 165
Cited by
Molecular mechanisms underlying nucleotide repeat expansion disorders
Malik, I., Kelley, C. P., Wang, E. T., & Todd, P. K. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00382-6 · Cited by 363
Thornton, C. A. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.04.011 · Cited by 377
Self-citationOkkersen, K., Jimenez-Moreno, C., Wenninger, S., Daidj, F., Glennon, J., Cumming, S., Littleford, R., Monckton, D. G., Lochmüller, H., Catt, M., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30203-5 · Cited by 123
Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD)
Hamel, J., Johnson, N., Tawil, R., Martens, W. B., Dilek, N., McDermott, M. P., & Heatwole, C. (2019) · Neurology · doi:10.1212/wnl.0000000000008123 · Cited by 88
Self-citationPatient‐identified disease burden in facioscapulohumeral muscular dystrophy
Johnson, N. E., Quinn, C., Eastwood, E., Tawil, R., & Heatwole, C. R. (2012) · Muscle & Nerve · doi:10.1002/mus.23529 · Cited by 65
Self-citation
Metadata
- Authors
- Heatwole, C., Bode, R., Johnson, N., Quinn, C., Martens, W., McDermott, M. P., Rothrock, N., Thornton, C., Vickrey, B., Victorson, D., & Moxley, R.
- Venue
- Neurology
- Published
- 2012-07-24
- Volume
- 79
- Issue
- 4
- Pages
- 348-357
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2102986002
- Cited by
- 214
- References
- 4
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). https://app.cochat.ai/papers/10.1212/wnl.0b013e318260cbe6
- The paper
- Heatwole, C., Bode, R., Johnson, N., Quinn, C., Martens, W., McDermott, M. P., Rothrock, N., Thornton, C., Vickrey, B., Victorson, D., & Moxley, R. (2012). Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology. https://doi.org/10.1212/wnl.0b013e318260cbe6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.